Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-10 (IL-10) producing CD4+ T lymphocytes are a specialized subset of T cells characterized by their ability to secrete the anti-inflammatory cytokine IL-10. These cells play a crucial role in immune regulation, limiting excessive inflammation and maintaining immune homeostasis. They can arise from various CD4+ T cell lineages, including Th1, Th2, Th17, and regulatory T cells. Their primary function is to suppress excessive inflammatory responses and limit tissue damage during infection, although this suppressive effect may also limit pathogen clearance or anti-tumor immunity.
Secretion of IL-10, suppression of APC activation, limitation of proinflammatory cytokine production, dampening of effector responses.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 10 Producing CD4+ T Lymphocyte (IL-10 producing CD4+ T cell).